Solventum completed its spin-off from 3M and is now an independent healthcare company trading on the New York Stock Exchange under the ticker symbol "SOLV." We are beyond excited that our CEO, Bryan Hanson, chose a Littmann Stethoscope as our gift to the nyse to symbolize our new organization’s commitment to leveraging the power of health, material, and data science, to improve patients' lives while empowering healthcare professionals to perform at their best. #WeAreSolventum #SOLV